Search results
Author(s):
David Playford
Added:
3 years ago
Prof David Playford (The University of Notre Dame, Perth, AU) discusses diastolic function and mortality in 436,360 individuals using findings from the National Echo Database of Australia (NEDA).
Questions:
1. What are the objectives behind NEDA?
2. What findings did you present at ESC?
3. What were the methods of the study?
4. What were the study’s results?
5. What conclusions can be made?
6…
View more
Author(s):
Federico Lombardi
Added:
3 years ago
Atrial fibrillation (AF) is the most common clinical arrhythmia with a relevant socio-economic impact.1–3 Patients with atrial fibrillation are characterised by symptoms such as palpitations and shortness of breath; they have reduced exercise capacity and are subject to a higher risk of thromboembolic events. In spite of a relatively simple diagnosis, management of AF patients is difficult for…
View more
Author(s):
Giovanni Luca Botto
,
Giovanni Tortora
,
Maria Carla Casale
,
et al
Added:
2 years ago
Author(s):
Anthony C Li
,
Amit Kaura
,
Nicholas Sunderland
,
et al
Added:
3 years ago
Since the 1990s, the publication of several large randomised controlled trials (RCTs) have established the efficacy of implantable cardioverter defibrillator (ICD) therapy in reducing the risk of sudden cardiac death (SCD) in high-risk patients. Collectively these trials have demonstrated a significant all-cause mortality reduction compared with medical therapy alone, for both the primary and…
View more
Author(s):
Rohin K Reddy
,
James P Howard
,
Yousif Ahmad
,
et al
Added:
4 months ago
Author(s):
Joshua R Silverstein
,
Demosthenes G Katritsis
,
Mark E Josephson
Added:
3 years ago
Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. The yearly incidence of SCD is estimated to be 3,000,000 worldwide and between 300,000–450,000 in both the US and Western Europe.1,2 The survival rate for SCD is <1 % worldwide and close to 5 % in the developed world.3 In the past, cardiac arrest was thought to be most commonly due to ventricular…
View more
Author(s):
Alex Baher
,
Nassir F Marrouche
Added:
3 years ago
AF is the most common rhythm disorder. It is estimated AF will affect 6–12 million Americans by 2050 and 17.9 million Europeans by 2060.1–4 AF is responsible for significant morbidity, mortality and healthcare costs.5–7 Heart failure with reduced ejection fraction (HFrEF) is also a rising epidemic that will afflict over 8 million Americans by 2030.8 AF is common in patients with HFrEF9,10 and…
View more
Author(s):
Roberto Keegan
,
Cynthia Yeung
,
Adrian Baranchuk
Added:
3 years ago
Chagas disease is an important public health problem in Latin America. Almost 25% of the population (approximately 65 million individuals) are at risk of infection and another 6 million people are affected.1 However, migration and globalisation have resulted in the increased presence of Chagas disease worldwide, particularly in the US and Europe.
Chagas disease is caused by a parasite, the…
View more
Author(s):
Deepika Narasimha
,
Anne B Curtis
Added:
3 years ago
Implantable cardiac devices such as implantable cardioverter- defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices lead to improved survival and better clinical outcomes in appropriately selected patients with heart failure (HF) with a reduced ejection fraction (EF). Although there are significant sex differences in the aetiology, pathophysiology and clinical course of HF,…
View more
Author(s):
Konstantinos D Rizas
,
Wolfgang Hamm
,
Stefan Kääb
,
et al
Added:
3 years ago
Experimental and clinical studies have demonstrated that enhanced sympathetic autonomic nervous system (SANS) activity can destabilise myocardial repolarisation,1–4 increasing vulnerability to developing fatal cardiac arrhythmias.5–8 Accordingly, assessment of SANS activity has always been a major goal for cardiac risk stratification methods. Various non-invasive methods including assessment of…
View more